Tiny study tracks enzyme levels in kids with rare disease before and after transplant

This study watches how the enzyme drug laronidase moves through the bodies of 13 children with MPS IH (a rare genetic disease) before and after they get a stem cell transplant. The goal is to learn what affects drug levels, not to test a new treatment. Children aged 0-3 who are already scheduled for transplant and enzyme therapy can join.